News of Note—Heartflow's noninvasive CAD test gets coverage in California, Alabama

Here's Friday's medtech news of note.

> Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama have issued a positive medical policy for Heartflow’s noninvasive coronary artery disease test, the Heartflow FFRct Analysis, which uses CT images to create a 3D model of a patient’s coronary arteries. Release

> Thermo Fisher set up a consortium in Europe to push the adoption of next-generation sequencing clinical research panels to help identify biomarkers associated with cancer immunotherapy. Release

> Hologic is rolling out its Brevera breast biopsy system, the first to combine tissue acquisition, real-time imaging, sample verification and advanced postbiopsy handling in one system. Release


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

> Baxter teams up with healthcare incubator Matter on products and technology based on patient-driven innovation. Release

> Abbott won reimbursement for its FreeStyle Libre glucose-monitoring system in Japan. Release

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.